Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boston Scientific Corporation
Compare rates of severe asthma exacerbations of subjects during the first and fifth year after BT treatment with the proportion of subjects who experience severe asthma exacerbations during the 12 months period prior to enrollment.
Compare baseline HRCT scans from subjects from the AIR2 study that enroll in BT 10+ study to examine if there are any clinically significant post-treatment respiratory changes following BT defined as bronchiectasis or bronchial stenosis.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects previously enrolled in AIR, RISA or AIR2
Subjects who received active BT treatment and had last BT treatment at least 10 years and 6 weeks prior to enrollment
Control/Sham subjects with at least 10 years of long-term follow-up from index date plus 6 weeks
Subject is able to read, understand and sign a written Informed Consent to participate in the Study and able to comply with the study requirements
You may not be if
Severe asthma exacerbation or chest infection in the past 4 weeks. Subject entry into this study should be delayed until free from severe asthma exacerbation or chest infection for a minimum of 4 weeks.
Clareo Health | Bronchial Thermoplasty 10+ Year Study
